edotreotide has been researched along with Sensitivity and Specificity in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Bockisch, A; Broelsch, CE; Frilling, A; Kuehl, H; Li, J; Malago, M; Radtke, A; Sotiropoulos, GC | 1 |
| Brenner, W; Hamm, B; Nogami, M; Pape, UF; Röttgen, R; Schreiter, NF; Steffen, I | 1 |
| Giesel, FL; Haberkorn, U; Kauczor, HU; Kratochwil, C; Ley, S; Mehndiratta, A; Moltz, JH; Wulfert, S; Zechmann, CM | 1 |
| Castaldi, P; Giordano, A; Rindi, G; Rufini, V; Treglia, G | 1 |
| Angelberger, P; Dudczak, R; Kienast, O; Kurtaran, A; Li, M; Li, S; Raderer, M; Schima, W; Traub-Weidinger, T; Virgolini, I | 1 |
| Angelberger, P; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Raderer, M; Szabó, M; Wunderbaldinger, P | 1 |
| Bijster, M; De Jong, M; Konijnenberg, MW; Krenning, EP | 1 |
| Barone, R; Borson-Chazot, F; Chauvin, F; Gogou, L; Jamar, F; Krenning, EP; Kvols, LK; Pauwels, S; Valkema, R; Walrand, S | 1 |
| Behe, M; Bucher, HC; Goetze, M; Heppeler, A; Jermann, E; Maecke, HR; Mueller-Brand, J; Otte, A; Roser, HW | 1 |
| Eichhorn, K; Freitag, P; Gratzl, O; Hofer, S; Maecke, R; Merlo, A; Mueller-Brand, J; Probst, A; Reubi, JC; Schumacher, T; Wasner, M; Zimmerer, S | 1 |
2 review(s) available for edotreotide and Sensitivity and Specificity
| Article | Year |
|---|---|
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
Topics: Algorithms; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, Somatostatin; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed | 2012 |
5 trial(s) available for edotreotide and Sensitivity and Specificity
| Article | Year |
|---|---|
Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Indium Radioisotopes; Iopamidol; Magnetic Resonance Imaging; Male; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2012 |
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Topics: Adult; Aged; Aged, 80 and over; Citrates; False Negative Reactions; False Positive Reactions; Female; Gallium; Heterocyclic Compounds; Humans; Indium Radioisotopes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Octreotide; Peptides, Cyclic; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.
Topics: Adult; Aged; Algorithms; Body Burden; Dose-Response Relationship, Radiation; Female; Gastrointestinal Neoplasms; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organ Specificity; Pancreatic Neoplasms; Radiation Injuries; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Relative Biological Effectiveness; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2005 |
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Topics: Adult; Aged; Brachytherapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Injections, Intralesional; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Receptors, Somatostatin; Sensitivity and Specificity; Treatment Outcome; World Health Organization; Yttrium Radioisotopes | 2002 |
4 other study(ies) available for edotreotide and Sensitivity and Specificity
| Article | Year |
|---|---|
The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
Topics: Adult; Aged; Disease Progression; Female; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.
Topics: Adult; Aged; Contrast Media; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Observer Variation; Octreotide; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Software | 2012 |
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Topics: Animals; Body Burden; Computer Simulation; Drug Evaluation, Preclinical; Femoral Neoplasms; Indium Radioisotopes; Lutetium; Metabolic Clearance Rate; Models, Biological; Octreotide; Organ Specificity; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Wistar; Relative Biological Effectiveness; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes | 2004 |
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.
Topics: Abdominal Neoplasms; Adult; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Yttrium Radioisotopes | 1997 |